Collectively, these results suggest that the expression levels of TWIST1 and CD274 (PD-L1) are positively correlated in ER−/HER2−/TWIST1+ breast cancer cells, including the TWIST1-reprogrammed MCF7-TWIST1 cell lines. This evidence concerns the gene CD274 and breast cancer.